EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pharmacologic stimulation of insulin granule acidification increases β-cell zinc content and augments β-cell-targeted drug delivery

Sooyeon Lee, Hannah P Fraser, Rebecca C Schugar, Haixia Xu, Timothy M Horton, Ella A Thomson, Julie Park, Xucheng Zhang, Justin P Annes

Journal of Biological Chemistry · 2025

DOI: 10.1016/j.jbc.2025.110645 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Sooyeon Lee und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Department of Medicine, Stanford University, Stanford, California, USA. Hauptthemen laut MEDLINE: Insulin-Secreting Cells, Zinc, Insulin, Drug Delivery Systems. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases, Juvenile Diabetes Research Foundation Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pathologic loss of insulin-producing pancreatic β-cells is a hallmark of diabetes that is potentially reversible through regenerative therapy. However, existing replication-promoting compounds lack β-cell specificity, limiting their clinical application. To overcome this challenge, we generated βRepZnC, a zinc-chelating replication compound designed to leverage the uniquely high zinc content of β-cells for targeted delivery. Herein, we identify pharmacological agents that boost β-cell zinc and improve the targeted delivery and bioactivity of βRepZnC. Using a high-content, image-based screen with the zinc fluorophore TSQ, we identified GR-46611 as a pharmacologic enhancer of β-cell zinc levels. Time-lapse TSQ imaging revealed that GR-46611 rapidly elevated intracellular zinc, prompting further mechanistic studies that showed increased zinc accumulation through the transporter ZnT8. This effect was mediated by enhanced V-ATPase-driven vesicle acidification via cAMP-PKA signaling inhibition. Supporting this mechanism, multiple protein kinase A (PKA) inhibitors also increased β-cell zinc content. Importantly, zinc enhancement significantly increased βRepZnC accumulation in both mouse and human primary islets, with fluorescence-activated cell sorting and mass spectrometry confirming selective drug retention in β-cells over non-β-cells. To evaluate effects on bioactivity, we performed complementary on-treatment and post treatment islet replication assays, measuring replication either concurrent with or 48 h after drug exposure, respectively. Zinc elevation via GR-46611 or the PKA inhibitor H89 selectively potentiated βRepZnC-induced β-cell replication in both contexts. Notably, only βRepZnC-unlike non-zinc-binding replication compounds-elicited a sustained replication response after drug withdrawal. This work defines a new pharmacologic strategy for manipulating β-cell zinc levels that can be exploited for durable β-cell-targeted therapeutic delivery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin-Secreting CellsZincInsulinDrug Delivery SystemsAnimalsMiceHumansCyclic AMP-Dependent Protein KinasesZinc Transporter 8Chelating Agents

Stichwörter der Autor:innen

PKAV-ATPaseZnT8beta cell (β-cell)cAMPdrug deliverypancreatic isletvesicle acidificationzincβ-cell replication

Substanzen

ZincInsulinCyclic AMP-Dependent Protein KinasesZinc Transporter 8Chelating Agents

Autor:innen und Institutionen

  • Division of Endocrinology, Department of Medicine, Stanford University, Stanford, California, USA.
  • Department of Electrical Engineering, Stanford University, Stanford, California, USA.
  • Department of Bioengineering, Stanford University, Stanford, California, USA.
  • Division of Endocrinology, Department of Medicine, Stanford University, Stanford, California, USA; Stanford ChEM-H and Diabetes Research Center, Stanford University School of Medicine, Stanford, California, USA. Electro…

Förderung

  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • Juvenile Diabetes Research Foundation Canada
  • National Institutes of Health
  • Juvenile Diabetes Research Foundation United States of America

Zitieren

APA

Lee, S., Fraser, H. P., Schugar, R. C., Xu, H., Horton, T. M., Thomson, E. A., Park, J., Zhang, X., & Annes, J. P. (2025). Pharmacologic stimulation of insulin granule acidification increases β-cell zinc content and augments β-cell-targeted drug delivery. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.110645

Vancouver

Lee S, Fraser HP, Schugar RC, Xu H, Horton TM, Thomson EA, et al. Pharmacologic stimulation of insulin granule acidification increases β-cell zinc content and augments β-cell-targeted drug delivery. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.110645

BibTeX
@article{Lee2025,
  author = {Lee, Sooyeon and Fraser, Hannah P and Schugar, Rebecca C and Xu, Haixia and Horton, Timothy M and Thomson, Ella A and Park, Julie and Zhang, Xucheng and Annes, Justin P},
  title = {Pharmacologic stimulation of insulin granule acidification increases β-cell zinc content and augments β-cell-targeted drug delivery},
  journal = {Journal of Biological Chemistry},
  year = {2025},
  doi = {10.1016/j.jbc.2025.110645}
}
Kostenlos starten →